Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

504
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
504

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome: A phase 2 study.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Fish-induced food protein-induced enterocolitis syndrome (FPIES) in children: Geography matters and tolerance is more than a challenge date.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Epinephrine Underuse for Anaphylaxis in Infants and Toddlers: A Practical Review for Pediatricians.

Paediatric drugs·2026
Same author

Erratum to "World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines update - IV - A quality appraisal with the AGREE II instrument" [World Allergy Organ J 15(2) (February 2022) 100613].

The World Allergy Organization journal·2026
Same author

Meaningful outcomes in food allergy immunotherapy: Measuring what counts.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Age-Appropriate Low Dosing for Food Protein-Induced Enterocolitis Syndrome Oral Food Challenges: Proposing a Standardized Approach.

The journal of allergy and clinical immunology. In practice·2026

相关实验视频

Updated: Jun 20, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K

实际关注小麦口服免疫疗法.

Stephanie Leeds1, Ami Belmont2, Holly Winfield3

  • 1From the Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.

Journal of food allergy
|July 18, 2024
PubMed
概括

小麦口服免疫疗法 (WOIT) 显示出对小麦过敏的个体脱敏的希望. 虽然研究仍在进行中,但目前的证据表明,WOIT可以在优化的协议下安全有效.

关键词:
:小麦小麦:小麦小麦:小麦小麦脱敏感化 脱敏感化质谷蛋白是一种口服免疫疗法是口服免疫疗法.

更多相关视频

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

16.9K

相关实验视频

Last Updated: Jun 20, 2025

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.1K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K
Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections
16:56

Sublingual Immunotherapy as an Alternative to Induce Protection Against Acute Respiratory Infections

Published on: August 30, 2014

16.9K

科学领域:

  • 过敏和免疫学 过敏和免疫学
  • 胃肠病学 胃肠病学
  • 临床营养学 临床营养学

背景情况:

  • 小麦是全球饮食的主食,也是普遍存在的食物过敏原.
  • 小麦口服免疫疗法 (WOIT) 是一种新兴的小麦过敏治疗方法.
  • 现有的WOIT研究包括具有方法限制的有限试验.

研究的目的:

  • 审查关于小麦口服免疫疗法 (WOIT) 疗效和安全性的当前文献.
  • 确定影响WOIT临床成功的因素.
  • 突出 WOIT 协议的未来研究领域.

主要方法:

  • 对小麦口服免疫疗法的现有临床试验进行系统审查.
  • 分析来自多中心,双盲,随机对照试验和开放式非随机试验的数据.
  • 评估研究局限性,包括样本大小,人口统计和治疗变化.

主要成果:

  • 大多数WOIT疗法在小麦过敏患者中表现出成功的无敏化.
  • 较长的治疗持续时间和较高的剂量似乎与临床成功的增加有关.
  • 报告了不良事件,主要是过敏反应,但随着时间的推移往往会减少.

结论:

  • 小麦口服免疫疗法 (WOIT) 显示出作为小麦过敏的安全有效治疗的潜力.
  • 需要进一步的研究来优化WOIT的剂量和持续时间,以提高疗效和安全性.
  • WOIT代表了一种有前途的治疗策略来控制小麦过敏,需要继续研究.